Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for SiSaf

    Client Virtual Booth

    SISAF

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    SiSaf
    unitedkingdom_new Flag
    Country
    Country
    United Kingdom
    Address
    Address
    3 Huxley Rd, Guildford GU2 7RE, United Kingdom
    Telephone
    Telephone
    +44 1483 912002
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.sisaf.com/
    Linkedin
    Linkedin
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    Publication of Positive Preclinical Data of SiSaf's SIS-ADO2 Program
    Publication of Positive Preclinical Data of SiSaf's SIS-ADO2 Program

    https://www.globenewswire.com//news-release/2023/09/18/2744460/0/en/Peer-Reviewed-Publication-of-Positive-Preclinical-Data-of-SiSaf-s-SIS-ADO2-siRNA-Program-to-Treat-Rare-Genetic-Bone-Disorder-Osteopetrosis.html

    GLOBENEWSWIRE
    18 Sep 2023
    Share Share
    SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer
    SiSaf Appoints Nikos Tzagkarakis in the New Role of Chief A.I. Officer

    https://www.globenewswire.com/news-release/2023/07/13/2704085/0/en/SiSaf-Appoints-Nikos-Tzagkarakis-in-the-New-Role-of-Chief-A-I-Officer.html

    GLOBENEWSWIRE
    13 Jul 2023
    Share Share
    FDA Grants SiSafs Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation
    FDA Grants SiSafs Innovative siRNA Therapy SIS-101-ADO Orphan Drug Designation

    https://www.globenewswire.com/news-release/2023/05/15/2668400/0/en/FDA-Grants-SiSaf-s-Innovative-siRNA-Therapy-SIS-101-ADO-Orphan-Drug-Designation-and-Rare-Pediatric-Disease-Designation-for-the-Treatment-of-Autosomal-Dominant-Osteopetrosis.html

    GLOBENEWSWIRE
    15 May 2023
    Share Share
    SiSaf Appoints Dr. Richard Goodfellow to Board of Directors
    SiSaf Appoints Dr. Richard Goodfellow to Board of Directors

    https://www.globenewswire.com/news-release/2023/04/05/2641367/0/en/SiSaf-Appoints-Dr-Richard-Goodfellow-to-Board-of-Directors.html

    GLOBENEWSWIRE
    05 Apr 2023
    Share Share
    SiSaf & the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA
    SiSaf & the University of Leipzig Partner to Develop Bio-Courier Targeted miRNA

    https://www.globenewswire.com/news-release/2023/03/02/2618970/0/en/SiSaf-and-the-University-of-Leipzig-Partner-to-Develop-Bio-Courier-Targeted-miRNA-for-the-Treatment-of-Pancreatic-Cancer.html

    GLOBENEWSWIRE
    02 Mar 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search